Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04286308 · ClinicalTrials.gov registry record · NA
Cortical-Basal Ganglia Speech Networks
A NA study of Parkinson Disease and Essential Tremor, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT04286308: Recruiting NA study of Parkinson Disease and Essential Tremor, sponsored by Massachusetts General Hospital.
NCT04286308 is a NA study of Parkinson Disease and Essential Tremor that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 80 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04286308, a NA study of Parkinson Disease and Essential Tremor, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
In this research study the researchers want to learn more about brain activity related to speech perception and production.
Primary Outcome
The number of subjects providing the interpretable speech related electrophysiological data during DBS surgery.
Conditions Studied
Interventions
- OTHER electrophysiological data collection
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2020-10-01 |
| Est. Completion | 2026-02 |
| Phase | NA |
What NCT04286308 shows while recruiting
NCT04286308 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (98% lower).
The record links to 3 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which electrophysiological data collection is the first listed.
NCT04286308 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04286308 about?
NCT04286308 is a clinical study titled "Cortical-Basal Ganglia Speech Networks". In this research study the researchers want to learn more about brain activity related to speech perception and production.
What is the current status of trial NCT04286308?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2020-10-01. Estimated completion is 2026-02.
What conditions does trial NCT04286308 study?
This clinical trial studies the following conditions: Parkinson Disease, Essential Tremor, Dystonia.
What interventions are being tested in trial NCT04286308?
The interventions under investigation include: electrophysiological data collection (OTHER).
Who is sponsoring clinical trial NCT04286308?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04286308 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04286308's enrollment target sits among peer trials
80 105th of 297 higher than 189 of 297 other Parkinson Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Parkinson Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Neurophysiology of Reward Signaling in Parkinson's Disease
RECRUITING · NA
-
Balance Tele-Rehab in Parkinson's Disease Parkinson's Disease
RECRUITING · NA
-
Rock Steady Boxing: A Community Based In Person Class
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI